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Abstract. With the shortage of physicians and surgeons and increase
in demand worldwide due to situations such as the COVID-19 pandemic,
there is a growing interest in finding solutions to help address the prob-
lem. A solution to this problem would be to use neurotechnology to
provide them augmented cognition, senses and action for optimal di-
agnosis and treatment. Consequently, doing so can negatively impact
them and others. We argue that applying neurotechnology for human
enhancement in physicians and surgeons can cause injustices, and harm
to them and patients. In this paper, we will first describe the augmen-
tations and neurotechnologies that can be used to achieve the relevant
augmentations for physicians and surgeons. We will then review selected
ethical concerns discussed within literature, discuss the neuroengineering
behind using neurotechnology for augmentation purposes, then conclude
with an analysis on outcomes and ethical issues of implementing human
augmentation via neurotechnology in medical and surgical practice.
Keywords: neurotechnology, ethics, augmentation, enhancement, brain-
computer interface, physicians, surgeons, patients, harm, global, social,
justice, malicious brain-hacking, personhood, brain data, discrimination,
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1 Introduction
The demand for medical and healthcare professionals continue to rise as the
overall world population continues to increase. This demand is further increased
when pandemics such as the SARS-CoV-2 outbreak, also known as the coron-
avirus disease COVID-19, occurs. The problem is that there is and may always
be a shortage of especially medical practitioners due to challenges and barriers
that exist to make it difficult for individuals to become physicians or surgeons.
Even if there were sufficient medical practitioners, the other problem is the lack
of resources that hospitals and institutions alike possess. Given that resources
are already a problem for hospitals, having sufficient clinicians would only make
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that worse. With recent advances in neuroscience and neurotechnology paving
ways to innovative applications that cognitively augment and enhance humans
in a variety of contexts, a solution to this would be to use neurotechnology to
augment the cognition and senses of medical practitioners to then augment their
actions [13]. In doing so, this will allow them to make optimal decisions and ac-
tions in less time, enabling them to treat more patients. As such, this makes
the solution along with the research and discussions pertaining to it highly im-
portant as not only does the solution impact directly impact physicians and
surgeons, but it also directly impacts patients as well. Additionally, as with any
technological intervention, it is important that not only are the technical as-
pects of the intervention are analyzed and discussed, but the ethical aspects are
as well. In approaching this technological intervention, we performed an ethi-
cal analysis on the application of neurotechnology for human augmentation in
physicians and surgeons, and found that even in the best-case scenario, apply-
ing neurotechnology for human augmentation in physicians and surgeons has a
significant negative impact on individuals, communities and countries.
In this paper, we argue that applying neurotechnology for human augmentation
to augment physicians and surgeons, and can cause personal identity, discrimina-
tion and financial issues for physicians and surgeons, and lead to patients being
harmed. The way that the paper is structured is as followed: we first describe the
augmentations and neurotechnologies that can be used to achieve the relevant
augmentations for physicians and surgeons, then review selected ethical con-
cerns discussed within literature particularly focusing on human rights, human-
computer interaction, data, brain-computer interface, global bioethics and drug
development, and discuss the neuroengineering behind using neurotechnology for
augmentation purposes. We then conclude with an analysis on outcomes and eth-
ical issues of implementing human augmentation via neurotechnology in medical
and surgical practice. The ethical analysis specifically focuses on social issues,
global health inequality and health migration, and patient harm, and includes
an assessment on personhood with respect to the neurotechnology users (i.e. the
physicians and surgeons). In this paper, we assume that all neurotechnologies
mentioned always succeeds in providing a person with augmentations, but the
type of augmentation provided by a neurotechnology is based on what its capa-
ble of. The motivation behind this assumption is to allow the paper to address
a possible best-case scenario with neurotechnology and human augmentation in
physicians and surgeons, and focus on ethical issues that arise with this scenario.
2 Human Augmentation and Neurotechnology
2.1 Types of Augmentations
Human augmentation can be formally defined as an interdisciplinary field that
addresses methods, technologies and their application for enhancing cognitive
abilities, senses and actions of humans [32]. In enhancing these leads us to aug-
mented cognition, augmented senses, and augmented actions. Augmented senses
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focus on enhancing ones ability to see, hear, smell, taste and touch. Augmented
cognition focuses on enhancing ones memory (short-term and long-term), at-
tention, learning capabilities, awareness, and knowledge. Augmented action can
be broken down to two parts: motion augmentation and gesture augmentation.
Motion augmentation would simply be improving ones ability to move, enabling
them to take actions that they may not normally be able to do such as carry
very heavy objects or run at a faster speed. Gesture augmentation is similar to
motion augmentation, except that it focuses more movement and positioning of
ones hand and head. For instance, being able to keep your hand in a specific
position for a long amount of time without fatigue and shaking would be con-
sidered augmented gesture and not motion augmentation. The end goal of both
augmentations is that the augmentation should allow the person to perform an
action optimally. From all the augmentations mentioned, we will only focus on
augmented senses (specifically augmented vision and augmented touch), aug-
mented cognition, and augmented action (specifically augmented gesture). The
motivation behind these augmentations in particular is because these augmen-
tations best allow physicians and surgeons to better diagnose and treat diseases
and disorders.
2.2 Augmentations Through Neurotechnology
From current technologies that are being developed, one such technology that
can be used to obtain these augmentations is neurotechnology. Neurotechnology
can be formally defined as an interdisciplinary field that combines neuroscience,
engineering and technology to create technical devices that are interfaces with
human nervous system. Within literature on neurotechnology, there has been a
considerable amount of work carried out on neurotechnologies for cognitive en-
hancement, specifically focusing on brain-computer interface (BCI), also known
as neuroelectronic interface [2], applications. Based on previous studies, neu-
rostimulation techniques, such as transcranial electric stimulation (tES) and
transcranial magnetic stimulation (TMS), can be used to improve performance
in different cognitive domains; these cognitive domains include perception, learn-
ing and memory, attention, and decision-making [13]. Accordingly, this can be
used to accomplish augmented vision and part of augmented cognition. Neuro-
modulation techniques, such as transcranial direct current stimulation (tDCS),
can also be used for memory, learning and attention [13]. Specifically, for tDCS,
studies have shown that it could improve performance in verbal problem-solving
task and other areas within complex problem solving [13]. This allows for further
enhancement of specific cognitive domains, as desired.
To address augmented touch while also addressing augmented action, a combina-
tion of tactile sensors and neuroprosthetics. Tactile sensors allow for perceiving
the location of the point of contact, discerns surface properties, and detection for
eventual slippage phenomena during the grasping and handling of an object [11].
Neuroprosthetics are devices that can enhance the input and output of a neural
system [5]. Combined together, they can allow for augmented gesture through
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enhancing the persons dexterous interaction with objects by ensuring that there
is a correct application of forces between the contact surfaces of the persons hand
and fingers and those of the object, and having the neuroprosthetic distinguish
brain activity patterns corresponding to the intention to act from control signals
of the hand itself [38]. To summarize, the neurotechnology that can be used to
accomplish the augmentations of interest is neurostimulation, neuromodulation,
tactile sensors and neuroprosthetics. How each of these neurotechnologies ac-
complish augmentations will be discussed later in the paper when We discuss
how neurotechnology can be applied in medical practice.
3 Ethics in Neurotechnology and Human Enhancement
3.1 Human Rights in Neurotechnology
While neurotechnology has the can help achieve human augmentation, it also has
the potential to impact human rights [22]. Three of the areas which neurotech-
nology is said to impact is the right to mental integrity, freedom of thought,
and freedom from discrimination. The right to mental integrity is a concern
with neurotechnology due to the problem of malicious brain-hacking. Malicious
brain-hacking is defined as the neuro-criminal activities that directly influence
neural computation in the users of neurotechnological devices in a manner that
resembles how computers are hacked in computer crimes [22]. For BCI appli-
cations, malicious brain-hacking can take place within BCI through having the
malicious agent (e.g. hacker) attack the level of measurement or decoding and
feedback of the BCI, or through the malicious agent manipulating the persons
neural computation through the BCI application. In such cases, the malicious
agent can add noise or override the signals sent to the neurotechnological device
with the objective of reducing or removing the control of the user over the BCI
application [22]. Furthermore, the malicious agent can also hijack the BCI users
voluntary control. For instance, a malicious agent can override the signals sent
from a BCI user, then hijack a BCI-controlled device (e.g. smartphone) without
the BCI users consent [22]. Ultimately, what results from malicious brain-hacking
is both the users mental privacy and their brain data being at risk due from the
loss of right to mental integrity. The loss of right to mental integrity leads to
the loss of freedom of thought as when malicious brain-hacking occurs, the BCI
user is no longer able to freely think of things due to the restraint placed by the
malicious agent.
One other human rights issue with neurotechnology is one that overlaps with
a health rights issue from human enhancement. The ethical issue from human
enhancement pertains to how the ability to augment ones physical or mental
performance raises several issues about fairness and justice regarding how aug-
menting technologies, such as neurotechnologies, should be accessed or regulated
[19]. What follows from this is the question of whether they are intended for mass
consumption or restricted to humans with identifiable impairments and disabili-
ties. In the case where neurotechnologies are intended for mass consumption and
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becomes commercialized, as with any other technology, it will likely be expensive
at the beginning [19]. Consequently, this could generate and even exacerbate so-
cietal divisions among the population or among inhabitants of different countries
[19]. Those of a low socio-economic status would not be able to afford to purchase
neurotechnologies. Subsequently, a digital divide is created between those that
can afford neurotechnology, and those that cannot. This leads to health right
issue as the digital divide creates an injustice to those of low socio-economic
status that cannot afford neurotechnology; they are indirectly being deprived of
something that is needed for their health and wellbeing. With the relationship
between poor mental health and the experience of poverty and deprivation being
well studied and an association between the two factors being established, com-
munities deprived of neurotechnology can cause those communities to experience
higher levels of deprivation and unemployment rates, leading to them experienc-
ing higher rates of psychiatric admissions for psychotic as well as non-psychotic
conditions and suicidal behavior [27].
3.2 Discrimination from Augmentation
The ongoing human rights concern regarding neurotechnology an freedom from
discrimination is that the use of neurotechnology will lead to discrimination
among individuals and groups. This concern is not only one that is valid, but
also strong evidence to support it. Throughout history, humans have shown that
existing moral code is often broken in practice, and that observable differences
between people, such as differences in race, gender, ethnicity, religion, sexual ori-
entation and/or ability, tend to lead to moral and social inequalities [7]. Given
that there will be a clear difference between those that adopt augmentation
technologies and those that do not and the actions that humans have taken in
the past and continue to take to this day, it is very likely that human augmen-
tation will lead to new, unjustified inequalities, and may even undermined the
core notion of moral equality used in Western societies [7]. Expanding on the
unjustified inequality, there is a growing concern regarding how new human aug-
mentation technologies can weigh more than personal experiences and benefits
[32]. Due to the cognitive enhancement that augmentation technologies provide,
those that utilize them will have a stronger say on matters than those that rely
solely on their personal experiences and benefits. Also, there is a concern that
neglecting potential negative effects of such technologies to daily life and society
can create problematic scenarios for the future [32]. One such potential negative
side effect comes from the pressure in adopting augmentation technologies. For
a long time and even now, people frequently experience prejudice if their bodies
or brain function differently from those around them [40]. With the integration
of augmentation technologies such as neurotechnology within society, this will
lead to people feeling pressure to adopt those technologies, and is likely to lead
to change societal norms. In turn, this will lead to issues of equitable access and
generate new forms of discrimination [40].
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To describe the forms of discrimination, we refer to self-identity, industry prac-
tice, and history. In self-identity, moral and social importance plays a crucial role
in how one people feel about themselves, and it plays a strong role in determining
peoples intentions, attitudes and behaviors [7]. Consequently, a poorly developed
self-concept could bring about low self-esteem, level of confidence, purpose and
reason to live, and level of motivation. With groups and communities determin-
ing collectively how one is treated by others, poorly formed self-concept could
make one subject to discrimination. Within industries, the discrimination can
take place as earlier as the job application process to later while the person is
employed with the company. In industry practice, it is common for companies to
hire the person that they think are best for the position. With neurotechnology
providing its users with augmentations, a complaint regarding this is that this
provides those people with an unfair advantage that will allow them to secure
jobs more easily, and that those that are augmented may view those that are not
augmented as inferior. This unfair advantage can lead to discrimination within
industries through employment.
The unfair advantage from augmentations can have serious implications in the
workplace especially once employers, administrators and decision-makers realize
that those with augmentation perform better than those without them [10]. The
realization will likely lead to them having a preference for those with augmen-
tations and a bias against those that do not have any augmentations, leading to
things such as them inquiring beforehand (or on the job for current employees)
whether an applicant has undergone an augmentation or utilizes neurotechnol-
ogy, and making decisions simply based on this information along with selected
other pieces of information from the applicant (or employee). This can lead
to prejudice, resulting in non-augmented people being discriminated against,
creating justice and equity issues. Note that this type of discrimination is not
limited to employment settings, and extends as far as in areas such as fam-
ilies and academic institutions. Between children, parents will give preference
to the child that performs best academically and professionally. Similarly, with
academic institutions, the institutions will prefer and reward those that per-
form best academically, and treat those that perform best academically better
than those that perform worse regardless of whether they have undergone any
sort of augmentation or not. We know this as in many academic institutions,
if students do not perform well enough academically, they are either removed
from their program, suspended or both, and those that perform well academi-
cally are rewarded awards, research and other opportunities, and scholarships.
As a result, in the long-term and possibly even in the short-term, the impli-
cations from the unfair advantage from augmentations can lead to a collapse
in the social process of education, care, interactions, relationships and more as
impartiality, open-mindedness, nondiscrimination, acceptance, and unbiasedness
would be minimized or lost completely in some groups and societies.
With neurotechnology and human enhancement possibly being enjoyed by the
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already privileged, if this possibility is realized, then this will lead to a failure
of distributive justice [18]. Of all communities, marginalized communities will
suffer the most from this failure. A major challenge experienced by underprivi-
leged communities comes from the fact that not only are they are often excluded
from opportunities, health services, development programs, resources and more,
but they often struggle to raise their voice in public discussions due to the lack
of access and autonomy [4]. As a result, underprivileged communities, including
women, LGBTQ groups, refugees, people with physical or mental disabilities,
people of low socio-economic status, and those that are less educated are often
ignored, deprived, or discriminated [4]. Among them, marginalized groups in
those communities are even more deprived, which this deprivation are sometimes
due to their physical or economic vulnerabilities, or various social and cultural
practices [4]. For example, in multiple places in the Indian subcontinent, women
are not allowed to use mobile phones due to social and cultural reasons [4]. Con-
sequently, this deprivation prevents them from obtaining the benefits from it -
one of them being that it can be used to cope with everyday stress [28]. In the
case where the group of Indian women were members of the LGBTQ group, this
deprivation of technological device can further negatively impact their mental
health. LGBTQ people have and continue to experience various forms of op-
pression and discrimination worldwide [21]. The oppression is in the form of
harassment and violence while the discrimination is experienced in areas such
as employment, housing, access to education and human services, and the law.
This oppressions and discrimination along with rejection, violence and harass-
ment have been shown to have negative physical and mental health effects on
both LGBTQ people [21]. Combining the primary societal stressors that many
LGBT people experience, that lead to minority stress [21], with deprivation of
mobile phones leads to those Indian women having less effective coping mecha-
nism options which are needed to deal with both everyday stress and minority
stress. Consequently, this results to there being major mental health disparities
between those Indian women within the LGBTQ population and other individ-
uals. From just the transgender individuals alone, the mental health disparities
can be severe enough to the point where the difference is that those individuals
have higher odds of depression symptoms and attempted suicides [39]. What the
failure of distributive justice will likely do is aggravate the everyday stress and
minority stress experienced by this marginalized group and others to an extent
where the majority of of the marginalized population will show depression symp-
toms, and a substantial amount of them may even commit suicide. As such, the
already marginalized communities will suffer more than they already are. The
repercussions of this will have negative impacts on both a local and global level.
3.3 Autonomy and Brain Data
Neurotechnology not only has the potential to impact human rights, but is can
also impact autonomy, confidentiality and protection. Note that it is possible
to obtain information through BCIs that can be extracted to reveal security
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breaches [26]. Neurotechnology such as BCI relies on multiple types of proba-
bilistic inference to be operationalized, for one to use any sort of probabilistic
inference requires a large amount of data [19]. This data, consisting of neural
information, is of high value to companies and individuals as neurotechnology
produces raw data in a way that enables a more direct detection pathway of
the neural correlates of mental processes, such as interests, intentions, mood
and preferences [23]. Additionally, the neural data includes rich and personally
identifiable sources of information that could be aggregated by data handlers
to apprehend or predict parts of health status, preferences and behavior [23].
An example of where neural information would be very useful is marketing and
advertising. The field of marketing has been interested in BCI research as they
are interested in utilizing a neuromarketing-based approach to marketing and
advertising [3]. Algorithms that are designed and used to target advertising can
better calculate things like insurance premiums through using neural informa-
tion [40]. Accordingly, investment in neural data (and computer scientists) is
something that marketing firms are striving to acquire, heavily investing time,
effort and money to obtain it.
Given the value of neural information, these motivate malicious agents, compa-
nies and corporations to perform malicious brain-hacking, or retrieve, aggregate
disseminate and use the information of the neurotechnology users without their
informed consent. In the case of malicious brain-hacking, after a malicious agent
has successfully hacked a device, rather than changing signals or taking control,
they can instead extract the data from the device, then abuse to them to as they
desire. Similarly, for companies and corporations behind a neurotechnological ap-
plication, they can either take the data collected from the neurotechnology users
as hostage of the users or sell the data to another entity or individual, with the
purpose of making more money. This has several consequences, including loss of
ownership of ones own data, loss of privacy, increase in level of distrust, data
used against them (e.g. for insurance purposes), Furthermore, with the malicious
hacker or entities not getting the consent from the users to take and sell their
data, the autonomy of the users is not respected.
3.4 Global Bioethics and Drug Development
The aftermath from a situation of malicious brain-hacking, neural data hostage,
or neural data sharing does not just impact an individual, but it impacts society
altogether. However, of the three, We will focus on neural data sharing, con-
tinuing the discussion from the point where what can occur after an individual,
corporation, or organization has obtained neural data as this is one of the biggest
concerns expressed within literature due to the impact that neural data sharing
has on society at large. What a person or entity will do with the neural data is
difficult to determine. However, it is easier for us to get a sense on what some
individuals and companies will do with the data compared to others. With the
advances in artificial intelligence and machine learning, when combining learn-
ing algorithms with brain data obtained through BCI or other neurotechnologies,
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they can lead to fruitful results for things such as drug development. However,
using BCI for drug development is not a simple task. Contemporary drug dis-
covery strategies rely on the identification of molecular targets associated with
a specific pathway and subsequently probe the role of a given gene product in
disease progression [6]. Subsequent to the identification of a relevant bioactive
compound, further compound screening can be achieved through phenotypic
screens. With phenotypic screens, they are capable of capturing complex cellu-
lar level behaviors that are physiologically relevant and central to a pathology
without relying on the identification of a specific drug target or a correspond-
ing hypothesis concerning its pathological role [6]. For that reason, phenotypic
screens are gradually becoming more utilized in drug discovery as using a phe-
notypic approach can generate novel treatments for diseases and disorders which
have either complex or unknown mechanisms [6]. When using a phenotypic ap-
proach onto a nervous system, it provides a way to find compounds and genes
active in a nervous system without assumptions about relevant molecular tar-
gets, which can possibly lead to new therapeutic targets, new disease biology,
and new compounds or genes [14]. The challenge is that phenotypic screens re-
quire a quantifiable phenotypic alteration, such as neuronal survival or changes
in fluorescently tagged protein expression in order to generate a usable output
[14]. Conveniently, BCIs can provide brain data containing neuronal survival [2].
With BCIs being able to extract quantifiable phenotypic alteration and classi-
fication algorithms being able to understand BCIs messages, we can conclude
that pharmaceutical companies that purchased neural data will most likely use
it with a phenotypic approach to discover, develop and patent new generic drugs.
The problems that follow this are societal and global health issues.
In the past, pharmaceutical companies have consistently argued that high prices
and multilateral patent protection afforded by Trade-Related Aspects of Intel-
lectual Property Rights are reasonable rewards for highly expensive and often
fruitless research and development of pharmaceutical products, which are ulti-
mately of benefit to society [9]. Furthermore, with pharmaceutical research and
development costs being substantial and given the low success rates, pharmaceu-
tical companies argued that profits from the few successful products are essential
[9]. Consequently, the problem with pharmaceutical companies researching and
developing drugs using neural data and phenotypic approach is that it will likely
be very expensive as not only will the companies have to pay a price for con-
ducting and developing the drug, but they also have to pay a price for neural
data based on the price set by the third party. For them to generate the data
can be even more costly for them as on top of cost associated with conduct-
ing data collection, hardware costs from neurotechnologies and costs associated
with data preprocessing and augmentation will need to be included in the total
cost. Furthermore, with patented drugs preventing others from making or us-
ing the generic drug without obtaining a license from the patent holder, most
pharmaceutical companies refuse to grant licenses so they can benefit from hav-
ing a limited monopoly on the drug [33]. As a result, not only will they likely
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enforce their patents on those generic drugs, but there is a chance that they
will also charge a hefty amount for those interested in purchasing the license for
it for therapeutic purposes. In turn, this will lead to affordability, accessibility
and health issues experienced by the portion of the population unable to afford
the drugs. On a global level, with the pharmaceutical companies enforcing their
patents, this will prevent developing countries from manufacturing the generic
versions of those drugs, creating affordability, accessibility and health issues ex-
perienced by those countries [8].
While it was easy to attempt to determine how pharmaceutical companies will
neural data, in the case of the military, for example, is not as obvious. The US
Department of Defense, for instance, is currently exploring the use of neurotech-
nologies and neural data [26]. It is said that in pursuing neurotechnology, they
are using it with the goal of restoring function following trauma from war and
to develop programs involving improving human training and performance [26].
From a first glance, it seems that they are doing it to help better those within
the military recover or become a better version of themselves. However, from
a closer look, this can be seen as the military trying to get an advantage over
other countries [26]. To make neurotechnologies use more extreme, yet more
effective for the military and even politicians and corporations such as those
that sell firearms, exploration of neurotechnologies such as brain implants by
the military can be used in a way that create a potential for terrorism [32],
leading to beneficence issues. This is an issue as this indirectly promotes war-
fare between countries, which the consequences from any sort of warfare which
neurotechnology contributed to includes an increase in casualties, environmen-
tal damage, loss of resources and infrastructure, psychological and neurological
disorder cases, loss of talent, and more. These casualties and other losses are a
major injustice to the innocent civilians caught in the middle of the warfare.
4 Augmentation of Physicians and Surgeons
4.1 Neuroengineering for Augmentations
Before moving onto how neurotechnology can be applied to medical practice,
it is important to have a foundational understanding of how the neurotech-
nologies that were mentioned earlier accomplish their respective augmentations.
How neurostimulation techniques accomplishes enhancing perception, learning
and memory, attention, and decision-making within a person is by using inva-
sive or non-invasive electrical stimulation systems on the person [17], to then
apply electricity to affect the persons central nervous system [37]. Similarly, how
neuromodulation accomplishes enhancing memory, learning, attention and com-
plex problem solving within a person is by sending electrical or pharmaceutical
agents to a target area of the persons brain to alter nerve activities [24]. While
there are several types of tactile sensors, the tactile sensor that would be best
for achieving augmented touch and augmented action is a tactile sensor using
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CNT-based nanocomposites because not only are they mechanically flexible, ro-
bust and chemically resistant needed to achieve the flexibility of human skin,
but they also require lower conductive phase concentration, which leads to bet-
ter mechanical properties of the composite [12]. The tactile sensors would be
placed onto a sensor glove, then worn by the user.
The way they work in achieving augmented touch is through optimizing the
use volume changes in sensitive materials to detect pressure [12], in a way that
allows the tactile sensors to be capable of [11]: (1) evaluating mechanical com-
pliance and surface texture properties of objects; (2) sensing an applied force by
evaluating the magnitude and direction; (3) spatially discriminating the point
of application of a force; and (4) Emulating the dynamic behavior of human
mechanoreceptors while tracking tactile stimuli overtime. Furthermore, the de-
sign criteria for the tactile sensors must consider spatial resolution and range
of applied force in order to properly achieve augmented touch [12]. Accordingly,
neuroprosthetics accomplishes augmented gesture and augmented touch by uti-
lizing tactile sensors with the BCI to receive relevant sensory information concur-
rently with letting the user directly control the output behavior of the prosthesis
(e.g. artificial arm movement); in doing so, this recreates the control-feedback
loop [1]. The signals produced by the loop provide output for controlled muscle
contractions, input and feedback from sensory organs (e.g. position), creating
a bidirectional pathway through which we explore and manipulate our environ-
ment [1], enabling for augmented gesture and augmented touch to take place.
Figure 1 illustrates the process of augmented gesture. The approach used in the
figure incorporates the neurofeedback approach an approach that is promising
for enhancing the performance of the brain [3].
Fig. 1: Diagram displaying the steps taken to obtain augmented gesture. First, the tac-
tile sensors that are places on the hands or fingers of the surgeon. Once measurements
are obtained, then they are sent to a controller (e.g. BCI) that evaluates, refines and
translates the measurements into stimulations that neurons can react to. Upon receiv-
ing the stimulations, the neural circuits within the neurons reorganize themselves in
a way that allows the surgeons brain to update itself on how to better perform the
gesture. The gesture is then realized through neuroprosthetics combined with either a
prosthetic or the surgeons hand.
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4.2 Augmentations in Surgery
Knowing how neurotechnology can realize augmentations within humans enables
us to address how such technology and augmentations will impact medical prac-
tice. For this section, we will specifically focus on the practice of surgery. In
this case, the users of the neurotechnology are surgeons. Within surgical set-
tings, augmented vision, augmented touch and augmented gesture will enable
surgeons to perform surgeries with a higher level of precision and accuracy by
allowing them to see details more clearly, utilize surgical tools and methods
better, and perform surgical procedures and operations better. As a result, the
success rate of surgeries performed by surgeons utilizing neurotechnology will
increase, which is good for multiple reasons; the main reason being that suc-
cessful surgery will enable the patient to live longer and healthier life, which
is helpful for the individual, their family and society. Augmented cognition for
surgeons enables surgeons to be able to learn new surgical procedures that are
less invasive, shorten operative times, lessens costs and reduce the likelihood
of complications. Furthermore, it will allow surgeons to be more knowledgeable
in surgical techniques and competent in the ability to recognize the limits of
their professional competence [36]. The benefits of these can best be understood
through a bioethics perspective, with specifically using the principle of benefi-
cence, non-maleficence and justice, In terms of beneficence, in neurotechnology
and the augmentations empowering surgeons, they enable surgeons to take ac-
tions, make suitable surgical judgements to assess the risks, burdens and benefits,
and approach surgeries in a way that that respects and is in the best the interest
of their patients. In addition, their improved cognitive abilities will allow them
to stay up to date with activities and update their knowledgebase as required.
With having surgeons keeping themselves professionally and educationally ad-
vanced, this will help ensure that they will provide the highest standards of
patient care and the lowest rates of complications [36]. This leads to non-
maleficence as higher standards of patient care is accompanied with better com-
munication and improvement in the type of care being offered (e.g. palliative
care), and lower rates of complications leads to a decrease in the likelihood of a
medical error occurring and minimization of harm caused to the patient. Lastly,
with the surgeons being able to perform tasks better, this will decrease the time
needed for surgeries, and can decrease the time of the patients stay in the hos-
pital. From a justice standpoint, this is crucial as just as much as health burden
is an issue for patients, so is economic burden. With surgeons successfully per-
forming surgeries on their patients, patients will not need to stay in the hospital
for long, enabling them to be able to live back their normal life and do their
regular activities, such as working and spending time with their family.
4.3 Augmentations in Medical Practice
For this section, we will focus on medical practice that do not involve surgery.
In this case, the users of the neurotechnology would be physicians. Within non-
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surgical settings, augmented vision and augmented cognition will allow physi-
cians to better perform diagnoses. For instance, given that the physician will have
enhanced vision and cognitive abilities, analysis of scans from diagnostic radiol-
ogy exams such as computed tomography (CT) and fluoroscopy would be better
performed as physician will be able to see details more clearly and better spot
indicators on the scans. As such, this will allow physicians to make more accurate
diagnoses, which can result in better understanding assessment, planning and
execution of treatment, communication between the physician and the patient,
maintain of the physicians fidelity and responsibilities, and care for the patient.
These help with achieving non-maleficence as effective diagnosis and communica-
tion significantly reduces the amount of harm within patients on both a physical
and mental level. Good diagnosis helps with increasing the chances that a cor-
rect treatment will be used, and prevents moral distress in patients and their
family. Additionally, and most importantly, with neurotechnology, augmented
vision and augmented cognition enhancing physicians diagnoses performance,
this leads to a major step towards justice. Specifically, improvement in diagnosis
will lead to reduction in discrimination, misclassification and prejudice experi-
enced by patients, and better provide freedom from misdiagnosis to patients.
Augmented cognition, augmented gesture and augmented touch from neurotech-
nology will allow physicians to perform treatments and therapy in a more efficient
and effective manner. The benefits of performing successful treatments and ther-
apy are similar to those of performing a successful surgery or diagnosis. Just as
in performing a successful surgery provides justice to the patient by allowing
them to leave the hospital and get back to their routinely activities, performing
a successful treatment is no different. However, given the difference in nature
of surgeries and treatments in terms of activities and procedures, there are par-
ticular benefits that neurotechnology and augmentations provides that applies
more for physicians than for surgeons. One of these benefits is how they help
physicians with meeting their fiduciary duty to their patients during treatment
through enabling physicians to properly implement precision medicine within
the treatment itself. What makes precision medicine desirable for treatments
is that its approach consists of utilizing the patients genes, environment, and
lifestyle. This is especially of interest for patients as they would much rather
have a treatment that is personalized for them than a one-size-fits-all treatment.
5 Ethical Analysis
5.1 Personhood Assessment
In the ethical evaluation of technological interventions, integrity and dignity of
a person are the most relevant criteria [29]. Within philosophical literature, a
portion of ethical questions raised in regard to neurotechnology are associated
with what we call our self or Soul, which the debate itself usually draws on the
concept of personhood as a modern notion that includes core aspects that we
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typically ascribe to our self or soul; these aspects include planning of the in-
dividual future and responsibility [29]. The concept of personhood always has
normative implications due to the fact that we describe certain attributes and
capabilities of a person, and want to have that person recognized, acknowledged
and guaranteed [29]. Just as patients must consciously authorize a neurotech-
nological intervention before it is conducted, physicians and surgeons must also
consciously provide authorization as well. As such, the concept of a person can
provide an ethical benchmark applicable to persons such as physicians and sur-
geons, assuming that we do not want to impair the personal capabilities, such
as autonomy and responsibility interventions in the brain [29]. With that being
said, neurotechnological interventions are ethically unacceptable if remaining a
person is at risk.
This statement poses major problems for neurotechnology and human augmen-
tation for physicians and surgeons for two reasons. To best understand those
reasons, we will provide two cases. Note that the concept of personal identity
refers to the query to which degree and under which circumstances a person
remains the same over time, above and beyond physical identity [29]. In inves-
tigating and evaluating for the sameness for a person, we need to consider both
the interaction that the person has with others and the appreciation of moral ca-
pabilities, such as the ability to make a promise and keep it [29]. This, especially,
is important for the physicians and surgeons as both of them have a fiduciary re-
sponsibility to their patients. Consider the simple case where all physicians and
surgeons provide authorization for augmentation via neurotechnology and neu-
rotechnology successfully accomplishes its augmentations on them without any
interference (i.e. no hackers or third parties involved). An undesired outcome that
can be produced from this comes from the augmented cognition. The increase in
knowledge does not guaranteed consistency or improvement in morality within a
person. As such, there is a chance that the cognitive enhancement that they have
undergone changes the way that they appreciate moral capabilities. A physician
with increase in knowledge on the importance of using a specific biomedical ap-
proach to treating patients with a specific condition can reinforce their current
belief that biomedical approaches are better than holistic approaches. In turn,
this can lead to a lack of openness for alternative approaches such as a holistic
approach, and empathy needed to understand why approaches like the holistic
approach is needed for the treatment of those kinds of patients. This will lead to
disputes and disagreements between the physician or surgeon and other physi-
cians and surgeons, and with medical practitioners such as nurses and clinical
social workers. Overtime, this will lead to the interaction that they have with
each other as well as with those medical professionals to change. By the end of
it, at the cost of wanting to improve their cognitive abilities for the sake of their
patients, the physician or surgeon will have lost their personal identity. This
possible loss of personal identity makes it problematic for neurotechnological
interventions as the physician or surgeon is at risk of not remaining the person
that he or she was prior to the augmentation.
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For the second case, consider the instance where simple case where all physi-
cians and surgeons provide authorization for augmentation via neurotechnology
and neurotechnology successfully accomplishes its augmentations on them, but
an interference by a third party, by say a malicious brain-hacker, occurs later.
After such an instance occurs, assuming that the negotiation with the malicious
brain-hacker was successful resulting in no changes made to the BCI and brain
of the physician or surgeon, it is pretty much guaranteed that the physician or
surgeon will not remain after the incident. The physician or surgeon will likely
suffer from sort of paranoia, trust issues, and/or psychological trauma. This is
not surprising as often when an individuals mental integrity and dignity has been
compromised, they end up suffering mentally from it to some degree. Further-
more, with the advancement of technologies and areas within computer science,
specifically artificial intelligence, machine learning and quantum computing, it
is justified for them to have fears and worries as there is no guarantee that the
same issue will not be experienced again. What that degree is heavily depends
on the persons mental strength, willpower and self-control, the amount of sup-
port provided to them after the incident has occurred, and the environment
where the person is situated after the occurrence of the incident. Regardless,
their interaction with physicians, surgeons and others will likely change and
their appreciation of moral capabilities will be altered as their view on them will
be called into question. In worst case scenario, they become diagnosed with a
psychological or neurological disorder as an aftermath or have their brain altered
by the malicious brain-hacker, guaranteeing that their interaction with others
and their appreciation of moral capabilities will change. This unintentional or
intentional loss of personal identity makes it problematic for neurotechnological
interventions as the physician or surgeon is at risk of becoming a new person
that he or she was not prior to the augmentation.
5.2 Social Issues
What can be noticed in the previous section is a third reason, or case as we can
call it, which is the case where some physicians and surgeons decides to either
not provide authorization to the neurotechnological intervention altogether or to
provide authorization to the neurotechnological intervention but not to undergo
at least one type of augmentation. The types of groups and a possible distribution
of these groups is shown in Figure 2. This case leads to one of the previously
raised concerns stemming from the consequence of human augmentation. As
discussed earlier, there is a chance that augmentations can lead to a divide
between humans, where the population of humans with augmentations will feel
that they are more superior to those without augmentation, leading to different
types of social issues. In our case with the physician or surgeon not providing
authorization to neurotechnological intervention, this divide can occur in three
different divides:
1. Division among physicians and surgeons domestically.
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Fig. 2: Diagram displaying the types of groups that would exist in the case where
undergo types of augmentations for physicians and surgeons are optional, and a possible
distribution of each group. To avoid providing false information, population percentages
were omitted.
2. Division between physicians and surgeons, and healthcare professionals.
3. Division between physicians, surgeons and healthcare professionals.
4. Division among physicians and surgeons internationally.
For our case, we will only mainly focus on (1) and (4) as (2) and (3) are more dis-
tant to the scope of the paper. However, those are areas that can and should be
further investigated. With there being four different groups, there is the change
that those that physicians and surgeons that are fully augmented (i.e. have
successfully undergone all augmentation via neurotechnology) mistreat those
that do not have the augmentations that they have. This possibility is not far-
fetched and is very likely to happen. In every industry, including healthcare and
medicine, we see prejudice and workers being mistreated due to their title, lack of
experience or the lack of knowledge that (at least according to the administration
or management within their organization). With those physicians and surgeons
that do not have a particular augmentation, such as and especially augmented
vision, cognition and touch, fully and semi augmented physicians and surgeons
can take advantage of that to enforce their agendas and ideologies and bypass-
ing arguments and statements made by them on the grounds that given their
inferiors cognitive abilities or senses, what they say and their opinions should
not be weighted equally to those that are fully augmented, or things along those
lines. As such, augmentations increase the chance of prejudice and mistreatment
occurring among physicians and surgeons, reinforcing existing beneficence, non-
maleficence and justice issues within healthcare and medicine. Overtime, this
can lead to alteration of personality among physicians and surgeons. Further-
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more, this can lead to moral distress, trust issues, and other psychological issues
experienced by those doctors that are mistreated, resulting in a loss of personal
identity. This is dangerous as this shift in personality and personal identity will
not only impact the performance of those physicians and surgeons and the lives
of patients, but can create or further contribute to suicidal thoughts within them.
Depending on the profile, involvements, commitments and types of patients that
the doctor was treating, the impact that their suicide can have can be one that
is negatively impacts individuals on a one-to-one, domestic, and/or international
level.
The other way in which physicians or surgeons can be discriminated is in an
instance where either malicious brain-hacking or a data hostage leading, with
either of them leading to data sharing occurs. What makes doctors neural data
valuable is that the doctors are known for being very well off financially. With
proper preprocessing of the neural data and correct use of data mining and ma-
chine learning algorithms, health status, preferences and behavior of physicians
and surgeons, physicians and surgeons can be exploited financially by companies
such as insurance companies. Note that data records are stored electronically,
which the highly personalized nature of neural data much like genomic data
may increase the identifiability of individuals [25]. With that being said, the
neural data obtained from malicious brain-hacking or data sharing could be
used for discrimination purposes against a particular physician or surgeon, or
to blackmail them into doing something. The severity of the consequences from
the blackmail will depend on what is being asked and whether the doctor carries
out the act. Regardless of what is produced from this scenario, as the risk of
psychological harms depends directly on the presence of other risks [16], it is
guaranteed that the doctor will experience distress, anxiety and other psycho-
logical issues, which can lead decreased performance in completing medical and
non-medical tasks. This decrease in performance increases the chances that they
harm the patient.
5.3 Global Health Inequality and Health Migration
Given that there are major economical, technological, and infrastructural dis-
parities among countries, it is inevitable that some countries will not be able
to provide their physicians and surgeons with the neurotechnological interven-
tions needed to obtain augmentations. As computing technologies can greatly
contribute to the growth and development of countries [4], countries such as the
United States, Germany and China that have the manpower, infrastructure and
resources to realize computing technologies for economic, social and medical de-
velopment will be able to provide their doctors with the augmentations quicker
and with guarantees compared to countries that are struggling due to poverty,
warfare and humanitarian crises such as Libya, Syria and Myanmar. Conse-
quently, if only doctors in developed countries are augmented, then this will cre-
ate a global health inequality. Patients in countries with augmented physicians
and surgeons will receive better treatment than those with regular physicians and
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surgeons. Furthermore, in times where doctors from different countries have to
collaborate together on medical and healthcare issues, conflicts will likely arise
between augmented doctors from one country (i.e. developed country) versus
regular doctors from another (i.e. underdeveloped country). With augmented
doctors possibly having a lack of openness for alternative approaches and em-
pathy towards patients from different countries, this will lead to disputes and
disagreements between the doctors from the different countries. The disputes and
disagreements can lead to physicians and surgeons experiencing distress, anxiety
and other psychological issues, resulting in decreased performance in complet-
ing medical and non-medical tasks. This decrease in performance increases the
chances that they harm their patients and patients internationally depending on
the case.
With developed and high-income countries being able to provide not just aug-
mentations to physicians and surgeons but also better employment opportuni-
ties, education, safety and security for them and their families, these will push
physicians and surgeons to migrate to those countries [34]. Their migration will
further contribute to the current disparity in the health workforce between high-
and low/middle-income countries [35]. In Serours work, which was done back
in 2009, she stated that Africa needs 1 million health workers, which includes
physicians and surgeons, for Sub-Saharan Africa alone. This number has likely
increased due to the SARS-CoV-2 outbreak that has and continues to take place
in 2020. With countries like the United States, United Kingdom, Canada and
Australia already benefitting considerably from the migration of nurses and doc-
tors (Naicker et al., 2010), the implementation of neurotechnology for human
augmentation will further benefit those countries as well as other developed
countries, leaving the underdeveloped countries to suffer more. What results
from this is an increase in harm experienced by the patients and an increase in
mortalities in the underdeveloped countries population.
5.4 Patient Harm
Whether it is data hostage situation of the data from a TMS or malicious brain-
hacking of a neuroprosthetic, given the risks associated with physicians and
surgeons using neurotechnology for augmentations along with the impact that
augmentation has on people in general, there is no doubt that there is a chance
that the change in self-concept, personal identity or the discrimination, psycho-
logical and other issues experienced by physicians and surgeons will influence
doctor-patient relationships. One of the reasons for why the relationship will
likely become worse is because the voices of the patients will either be ignored
or be of less value to their physicians and surgeons. For fully or semi augmented
physicians and surgeons, especially those with augmented cognition, there is a
higher chance that they will think that whatever decision they make will be
the right decision for the patient. Consequently, when patients of theirs voice
their concern to them, they will either ignore or listen only selected parts of the
concern. In turn, this will make the patient feel as if their doctor does not care
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for them, leading to feelings of sadness, distress, and pain. This is problematic
because even in the case where the patient is successfully treated, they would
leave the hospital or clinic feeling mentally hurt. While the degree in which the
mental pain from the experienced differs from one patient to the other, it is still
a problem because the physician or surgeon did not accomplish non-maleficence.
During times when they could have prevented the patient from experiencing
mental harm, they did not prevent it. As a result, the physician or surgeon did
not ensure to inflict the least amount of harm possible to reach a beneficial out-
come. Rather, they inflicted an amount of harm onto the patient that either they
were not aware of or did not care about enough to reach a beneficial outcome.
The other reason for why doctor-patient relationships will likely worsen is be-
cause of the side effects experienced by physicians and surgeons from either
undergoing all augmentations or selected few augmentations, and/or from being
mistreated and discriminated by their colleagues [15]. For fully or semi aug-
mented physicians and surgeons, in the case where they lose their personal iden-
tity, this can make it difficult for patients to communicate their concerns as
the new personality developed by their physician or surgeon can be one that
makes it difficult to communicate with them, and vice-versa. Consequently, in
the physician or surgeon having difficulty communicating with their patients,
this increases the chances of and eventually lead them harm their patients either
by accident or on purpose. In the case of harm occurring due to an accident,
this accident could be due to the physician or surgeon making a wrong as-
sumption based on the limited information verbally provided by their patients.
Alternatively, this can also be due to after using tES to increase the physician
or surgeon memory, rather than the memory being used for remembering details
about the patients, the memory retrieval within the physician or surgeons brain
retrieves unrelated information or even problematic information such as details
of a traumatic event; in retrieving the wrong information, the physician or sur-
geons attention is not adequately concentrated on the patient, making it difficult
for them to communicate with the patient, and eventually leading to them ac-
cidentally harming the patient. In the case of harm occurring on purpose, this
could be due to first the personal identity change resulting in the physician or
surgeon not being able to properly control their anger, then the patient criticiz-
ing the physician or surgeon, infuriating the doctor in a way that made them
feel that the patient is attacking their expertise, experiences and augmentations.
The problem of the voices of patients being ignored extends to issues of justice.
What results from the patients voice being partially or fully ignored is unequal
and unfair treatment by the fully or semi augmented physicians and surgeons to
their patients. The way that they approached the medical intervention was not
the same across all of their patients. Some received more care from the physicians
or surgeons while others received less. Consequently, this unequal level of care is
unfair to those that do not receive the same amount of care from the physicians
or surgeons. This unequal treatment to patients can not only be experienced
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while undergoing the medical intervention, but it can be experienced prior to it
as well. Especially with augmented cognition, augmented vision and BCIs, those
make it possible for physicians and surgeons to easily take advantage of their
patients during the diagnosis and consent phase prior to the treatment. With
tDCS providing physicians and surgeons the ability to better solve complex prob-
lems, they can find ways to trick patients into providing their informed consent
to treatments that are either costly, ineffective, harmful or all three combined.
Consequently, this will lead to the patient further suffering from the disease and
any complications that arise during the medical intervention, financial loss, and
increased levels of distress from spending a larger than expected time in the
hospital and from the worry of either dying or possibly not being able to live a
regular life again or anytime soon.
6 Conclusion
A limitation with our work is that there were no medical professionals that di-
rectly contributed to the paper. As such, there are some notable ethical issues
that were not included in this paper. Additionally, as our work did not include
any discussions on health policy and cyber security, we were not able to discuss
solutions that could be used to address the ethical and health issues. Future
work can ethically analyze the impact of neurotechnology for human augmenta-
tion on physicians and surgeons with respect to the division between physicians,
surgeons and healthcare professionals, and should focus on health policy and
cyber security needed to address those ethical and health issues. Even with the
best-case scenario where neurotechnology always succeeds in providing people
with augmentations, in applying it on physicians and surgeons to augment them,
there are high risk associated with it. This makes it challenging when it comes to
doing a cost benefit analysis of it, especially because when doing such an anal-
ysis, we cannot make the big assumption that we made in this paper. A way to
reduce the risks associated with the neuroengineering component of augmenting
physicians and surgeons is to design and program the tactile sensors and neu-
roprosthetics so that in a worse case where a malicious brain-hacker takes over
a surgeons BCI and tries to make the surgeon harm their patient, the neuro-
prosthetic detects the abnormality then communicates with the tactile sensors,
activating the emergency magnet mechanism in the glove, forcing the gloves to
tighten together like handcuffs. This will prevent the surgeon from harming the
patient and medical practitioners in the room, and give the surgical team time
to figure out what to do next. It is important that such safety mechanisms like
these and others are rigorously tested prior to using them in clinical settings,
and have them ready for use once they are ready to be used. Furthermore, af-
ter augmentations have been embedded within physicians and surgeons, have a
designated medical and bioethics combined team dedicated to supporting them
mentally to ensure that the transition is smooth and the physicians and surgeons
personal identity and other crucial aspects of them are preserved. In doing so,
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this can help reduce and prevent the occurences of harm and ethical, medical,
and personhood issues experienced by physicians, surgeons and patients.
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